|Articles|March 19, 2020
Oncology Product Manufacturing in a Nondedicated Facility
Author(s)Baxter BioPharma Solutions
- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation
Related Content
Trending on Pharmaceutical Technology
1
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
2
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
3
Technology Transfer: Success Drivers and Obstacles Explained
4
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
5